PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Kardigan, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Kardigan, Inc.'s yearly results, compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

Cash quality

Profit Cash Ratio

—

Data incomplete

Self-Funding Ratio

—

Data incomplete

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

—

Data incomplete

Growth Efficiency Ratio

—

Data incomplete

Asset Productivity Ratio

—

Data incomplete

Balance-sheet strength

Debt Due Cover Ratio

-48.1×

Operating cash was negative last year, while some debt falls due within a year.

Lower than 72% of Healthcare companies in United States.

Cash Cushion Ratio

+27%

Cash, after subtracting all debt, equals 27% of its market value (net cash).

Higher than 67% of Healthcare companies in United States.

Tangible Assets Ratio

94%

Of every $100 the company owns, $94 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 69% of Healthcare companies in United States.

Tangible Net Worth Ratio

—

Data incomplete

Shareholders

Shareholder Slice Ratio

—

Data incomplete

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (9)

Kardigan, Inc. made a loss over the last year. Kardigan, Inc. owes $0.15 for every $1 it owns. Kardigan, Inc. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Kardigan, Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

1.94

The share price is 1.94 times Kardigan, Inc.'s book value per share, lower than 60% of Healthcare companies in United States.

Market cap

$1.2 B

The total market value of all of Kardigan, Inc.'s shares at today's price (share price × number of shares), larger than 66% of Healthcare companies in United States. PosiCap size class: Meso Cap.

Net worth (book value)

$616 M

What Kardigan, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$6.58

Net worth divided by the number of shares. The share price of $12.80 is 1.9 times this, which is the P/B above.

Owes vs Owns

0.15×

Kardigan, Inc. owes $0.15 for every $1 it owns (low), lower than 80% of Healthcare companies in United States.

Dividend yield

None

Kardigan, Inc. does not currently pay a dividend.

Profit growth

Loss

Kardigan, Inc. made a loss in each of the last two years.

Cash vs debt

Net cash

Kardigan, Inc. held $322 M more cash than debt (net cash) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Kardigan, Inc.: $1.2 B ÷ $616 M (30 Jun 2026) = 1.9.

How much does Kardigan, Inc. owe compared with what it owns?

Kardigan, Inc. owes $0.15 for every $1 it owns (low), lower than 80% of Healthcare companies in United States.

Does Kardigan, Inc. pay a dividend?

No. Kardigan, Inc. does not currently pay a dividend.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.